- Definition, Diagnosis, and Prevalence of Occult Hepatitis B Virus Infection
-
Kim YS
- KMID: 1707195
- Korean J Gastroenterol.
- 2013 Sep;62(3):143-147.
- doi: 10.4166/kjg.2013.62.3.143
Occult HBV infection is characterized by the absence of serum HBsAg with persistence of low level of intrahepatic HBV DNA. Several suggested mechanisms for the origin of occult HBV infection... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
-
Yim SY, Kim TH, Jun SS, Kim ES, Keum B, Seo YS, Yim HJ, Jeen YT, Chun HJ, Lee HS, Um SH, Kim CD, Won NH, Ryu HS
- KMID: 2412216
- Gut Liver.
- 2017 May;11(3):417-425.
- doi: 10.5009/gnl16148
BACKGROUND/AIMS: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
- Occult Hepatitis B Virus Infection: Transmission and Reactivation
-
Song SH, Hwang SG
- KMID: 1707196
- Korean J Gastroenterol.
- 2013 Sep;62(3):148-153.
- doi: 10.4166/kjg.2013.62.3.148
Occult HBV infection (OBI) is defined as presence of HBV DNA in the liver tissue in patients with serologically undetectable HBsAg. There are differences in virologic and serological profiles of... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients
-
Yoo JH, Hwang SG, Yang DH, Son MS, Kwon CI, Ko KH, Hong SP, Park PW, Rim KS
- KMID: 1775760
- Korean J Gastroenterol.
- 2013 Apr;61(4):209-214.
- doi: 10.4166/kjg.2013.61.4.209
BACKGROUND/AIMS: The prevalence of occult HBV infection depends on the prevalence of HBV infection in the general population. Hemodialysis patients are at increased risk for HBV infection. The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
- A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience
-
Oh MJ, Lee HJ
- KMID: 1493575
- Clin Mol Hepatol.
- 2013 Mar;19(1):51-59.
- doi: 10.3350/cmh.2013.19.1.51
BACKGROUND/AIMS: The widespread use of cytotoxic chemotherapy and immunosuppressants has resulted in reactivation of hepatitis B virus (HBV) recently becoming an issue. Although rituximab (an anti-CD20 monoclonal antibody) has revolutionized... -
- CITED
-
- Close
- SHARE
-
- Close
